Upadacitinib for Acute Severe Ulcerative Colitis
Inflammatory Bowel Diseases · 03.10.2023 · 29 (10) · 1667-1669
DOI: 10.1093/ibd/izad180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 23.08.2023. Verfasst von Chen Hasya Zinger und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Meir Medical Center, Kfar Saba, Israel. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Meir Medical Center, Kfar Saba, Israel.
- Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel.
ORCID-Profile: Chen Hasya Zinger
Zitieren
APA
Zinger, C. H., Ringel, Y., Eitan, M., Openhaim, M., Kayless, H., Stein, A., Rudnicki, Y., & Naftali, T. (2023). Upadacitinib for Acute Severe Ulcerative Colitis. Inflammatory Bowel Diseases, 29(10), 1667-1669. https://doi.org/10.1093/ibd/izad180
Vancouver
Zinger CH, Ringel Y, Eitan M, Openhaim M, Kayless H, Stein A, et al. Upadacitinib for Acute Severe Ulcerative Colitis. Inflammatory Bowel Diseases. 2023;29(10):1667-1669. doi:10.1093/ibd/izad180
BibTeX
@article{Zinger2023,
author = {Zinger, Chen Hasya and Ringel, Yehuda and Eitan, Mayan and Openhaim, Michal and Kayless, Hen and Stein, Assaf and Rudnicki, Yaron and Naftali, Timna},
title = {Upadacitinib for Acute Severe Ulcerative Colitis},
journal = {Inflammatory Bowel Diseases},
year = {2023},
volume = {29},
number = {10},
pages = {1667--1669},
doi = {10.1093/ibd/izad180}
}
EUVIMED